{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-001940","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2024-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.125719+00:00","generated_at":"2026-06-07T00:53:30.390414+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"INVO Bioscience, Inc. enters $5M Series A Preferred Stock purchase agreement with NAYA Biosciences","bullets":["NAYA to purchase up to 1,000,000 shares of Series A Preferred Stock at $5.00/share, total up to $5,000,000.","First tranche of $500,000 closed on January 4, 2024 for 100,000 shares.","Remaining tranches: $500,000 each by Jan 19, Feb 2, Feb 16, 2024, plus additional amount for merger.","Proceeds to support INVO's fertility business, including catch-up on past due payables.","Agreement is in connection with previously announced merger between INVO and NAYA."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-001940","json":"https://secwatch.observer/filing/0001493152-24-001940.json","markdown":"https://secwatch.observer/filing/0001493152-24-001940.md","text":"https://secwatch.observer/filing/0001493152-24-001940.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224001940/0001493152-24-001940-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224001940/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:53:30.390414+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"224603922dc6d8169138a5ef16d353b9b9d80b54","claim":"INVO Fertility, Inc. entered into SPA with NAYA Biosciences, Inc. valued at $5.00 per share (effective 2023-12-29).","evidence_excerpt":"On December 29, 2023, INVO Bioscience, Inc., a Nevada corporation (the “ Company ”) entered into securities purchase agreement (the “ SPA ”) with NAYA Biosciences, Inc., a Delaware corporation (“ NAYA ”) for the purchase of 1,000,000 shares of the Company’s Series A Preferred Stock at a purchase price of $5.00 per share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224001940/0001493152-24-001940-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"NAYA Biosciences, Inc."},{"label":"Value","value":"$5.00 per share"},{"label":"Effective","value":"2023-12-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}